Non-melanoma skin cancer in mouse and man

Archives of Toxicology

Volumn 87, Issue 5, 2013, Pages 783-798

  Schwarz, Michael ^a   Münzel, Peter A ^a   Braeuning, Albert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Chemical carcinogenesis; Ha ras signaling; Papilloma; Phorbol ester; Squamous cell carcinoma; Wnt signaling

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; PHORBOL ESTER; TUMOR PROMOTER; PHORBOL 13 ACETATE 12 MYRISTATE;

CANCER GROWTH; CANCER RISK; CARCINOMA; EPIDERMIS; HOMEOSTASIS; HUMAN; NON MELANOMA SKIN CANCER; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SKIN CARCINOGENESIS; SPECIES DIFFERENCE; STRAIN DIFFERENCE; TATTOOING; TUMOR PROMOTION; ANIMAL; CANCER STEM CELL; CHEMICALLY INDUCED DISORDER; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; GENETICS; MELANOMA; MOUSE; MUTATION; ONCOGENE RAS; PATHOLOGY; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

ANIMALIA; MUS; RODENTIA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENES, P53; GENES, RAS; HUMANS; MELANOMA; MICE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; PAPILLOMA; RISK ASSESSMENT; SKIN; SKIN NEOPLASMS; SPECIES SPECIFICITY; TETRADECANOYLPHORBOL ACETATE;

EID: 84886928127     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-012-0998-9     Document Type: Review

References (131)

1. Adams CL, Nelson WJ, Smith SJ (1996) Quantitative analysis of cadherin-catenin-Actin reorganization during development of cell-cell adhesion. J Cell Biol 135(6 Pt 2):1899-1911
2. Allen TD, Potten CS (1974) Fine-structural identification and organization of the epidermal proliferative unit. J Cell Sci 15(2):291-319
3. Balmain A, Brown K (1988) Oncogene activation in chemical carcinogenesis. Adv Cancer Res 51:147-182
4. Beaudoin GM 3rd, Sisk JM, Coulombe PA, Thompson CC (2005) Hairless triggers reactivation of hair growth by promoting Wnt signaling. Proc Natl Acad Sci USA 102(41):14653-14658
5. Berenblum I, Shubik P (1947) A new, quantitative, approach to the study of the stages of chemical cartinogenesis in the mouse's skin. Br J Cancer 1(4):383-391
6. Bertsch S, Marks F (1974) Lack of an effect of tumor-promoting phorbol esters and of epidermal G1 chalone or DNA synthesis in the epidermis of newborn mice. Cancer Res 34(12):3283-3288
7. Boutwell RK (1964) Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res 19:207-250
8. Boutwell RK, Verma AK, Ashendel CL, Astrup E (1992) Mouse skin: a useful model system for studying the mechanism of chemical carcinogenesis. In: Hecker E, Fusenig N, Kunz W, Marks F, Thielmann HW (eds) Carcinogenesis: a comprehensive survey, vol 7. Raven Press, New York
9. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J (1991) A role of sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128
10. Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S, Balmain A (1986) v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 46(3):447-456
11. Brown K, Buchmann A, Balmain A (1990) Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc Natl Acad Sci U S A 87(2):538-542
12. Brown K, Strathdee D, Bryson S, Lambie W, Balmain A (1998) The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr Biol 8(9):516-524
13. Buchmann A, Ruggeri B, Klein-Szanto AJ, Balmain A (1991) Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res 51(15):4097-4101
14. Burns F, Albert R, Altshuler B, Morris E (1983) Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model. Environ Health Perspect 50:309-320
15. Burns FJ, Albert RE, Altschuler B (1984) Cancer progression in mouse skin. In: Saga TJ (ed) Mechanisms of tumor promotion, vol 2. CRC Press, Boca Raton, pp 17-39
16. Cacace AM, Ueffing M, Philipp A, Han EKH, Kolch W, Weinstein IB (1996) PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 13(12):2517-2526
17. Cachon-Gonzalez MB, Fenner S, Coffin JM, Moran C, Best S, Stoye JP (1994) Structure and expression of the hairless gene of mice. Proc Natl Acad Sci U S A 91(16):7717-7721
18. Chan EF, Gat U, McNiff JM, Fuchs E (1999) A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet 21(4):410-413
19. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A, Akhurst RJ (1996) TGF-beta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542
20. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y, Khavari PA (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421(6923):639-643
21. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91(2):231-241
22. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278(5338):687-689
23. Dipple A, Pigott M, Moschel RC, Costantino N (1983) Evidence that binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res 43(9):4132-4135
24. Ehrenreiter K, Kern F, Velamoor V, Meissl K, Galabova-Kovacs G, Sibilia M, Baccarini M (2009) Raf-1 addiction in Ras-induced skin carcinogenesis. Cancer Cell 16(2):149-160
25. Fan H, Oro AE, Scott MP, Khavari PA (1997) Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med 3(7):788-792
26. Finch JS, Albino HE, Bowden GT (1996) Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP. Carcinogenesis 17(12):2551-2557
27. Friedewald WF, Rous P (1944a) The determining influence of tar, benzpyrene, and methylcholanthrene on the character of the benign tumors induced therewith in rabbit skin. J Exp Med 80(2):127-144
28. Friedewald WF, Rous P (1944b) The initiating and promoting elements in tumor production : an analysis of the effects of tar, benzpyrene, and methylcholanthrene on rabbit skin. J Exp Med 80(2):101-126
29. Fujiki H, Suganuma M (1993) Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv Cancer Res 61:143-194
30. Fujiki H, Suganuma M (2005) Translational research on TNF-Alpha as an endogenous tumor promoter and green tea as cancer preventive in humans. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 23(1):3-30
31. Fujiki H, Suganuma M (2009) Carcinogenic aspects of protein phosphatase 1 and 2A inhibitors. Prog Mol Subcell Biol 46:221-254
32. Furstenberger G, Kopp-Schneider A (1995) Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin. Carcinogenesis 16(1):61-69
33. Furstenberger G, Berry DL, Sorg B, Marks F (1981) Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci U S A 78(12):7722-7726
34. Furstenberger G, Kinzel V, Schwarz M, Marks F (1985a) Partial inversion of the initiation-promotion sequence of multistage tumorigenesis in the skin of NMRI mice. Science 230(4721):76-78
35. Furstenberger G, Schweizer J, Marks F (1985b) Development of phorbol ester responsiveness in neonatal mouse epidermis: correlation between hyperplastic response and sensitivity to first-stage tumor promotion. Carcinogenesis 6(2):289-294
36. Gailani MR, Stahle Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE, Toftgard R (1996) The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14(1):78-81
37. Gat U, DasGupta R, Degenstein L, Fuchs E (1998) De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95(5):605-614
38. Ghazizadeh S, Taichman LB (2001) Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J 20(6):1215-1222
39. Goerttler K, Loehrke H, Schweizer J, Hesse B (1980a) Positive twostage carcinogenesis in female Sprague-Dawley rats using 7,12-dimethylbenz(a) anthracene (dmba) as initiator and 12-o-Tetradecanoylphorbol-13-Acetate (tps) as promotor. Results of a pilot study. Virchows Arch A Pathol Anat Histol 385(2):181-186
40. Goerttler K, Loehrke H, Schweizer J, Hesse B (1980b) Two-stage tumorigenesis of dermal melanocytes in the back skin of the Syrian golden hamster using systemic initiation with 7,12-dimethylbenz(a)anthracene and topical promotion with 12-Otetradecanoylphorbol-13-Acetate. Cancer Res 40(1):155-161
41. Goerttler K, Loehrke H, Hesse B, Schweizer J (1984) Skin tumor formation in the European hamster (Cricetus cricetus L.) after topical initiation with 7,12-dimethylbenz[a]anthracene (DMBA) and promotion with 12-O- Tetradecanoylphorbol-13-Acetate (TPA). Carcinogenesis 5(4):521-524
42. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE (1996) Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85(6):841-851
43. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, Da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281(5382): 1509-1512
44. He J, Sheng T, Stelter AA, Li C, Zhang X, Sinha M, Luxon BA, Xie J (2006) Suppressing Wnt signaling by the hedgehog pathway through sFRP-1. J Biol Chem 281(47):35598-35602
45. Hecker E (1963) Ü ber die Wirkstoffe des Crotonöls. Z Krebsforsch 65:325-333
46. Hecker E (1981) Cocarcinogenesis and tumor promoters of the diterpene ester type as possible carcinogenic risk factors. J Cancer Res Clin Oncol 99(1-2):103-124
47. Hecker E (1987) Three stage carcinogenesis in mouse skin-recent results and present status of an advanced model system of chemical carcinogenesis. Toxicol Pathol 15(2):245-258
48. Hennings H, Spangler EF, Shores R, Mitchell P, Devor D, Shamsuddin AK, Elgjo KM, Yuspa SH (1986) Malignant conversion and metastasis of mouse skin tumors: a comparison of Sencar and CD-1 mice. Environ Health Perspect 68:69-74
49. Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH (1993) FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 14(11):2353-2358
50. Hickey TA, Worobec SM, West DP, Kinghorn AD (1981) Irritant contact dermatitis in humans from phorbol and related esters. Toxicon 19(6):841-850
51. Holsti P (1959) Tumor promoting effects of some long chain fatty acids in experimental skin carcinogenesis in the mouse. Acta Pathol Microbiol Scand 46(1):51-58
52. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W (2001) beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105(4):533-545
53. Hunter T (1997) Oncoprotein networks. Cell 88(3):333-346
54. Ingham PW (1998) Transducing Hedgehog: the story so far. EMBO J 17(13):3505-3511
55. Ito M, Liu Y, Yang Z, Nguyen J, Liang F, Morris RJ, Cotsarelis G (2005) Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med 11(12):1351-1354
56. Jansen LA, Mesnil M, Jongen WM (1996) Inhibition of gap junctional intercellular communication and delocalization of the cell adhesion molecule E-cadherin by tumor promoters. Carcinogenesis 17(7):1527-1531
57. Jensen PJ, Telegan B, Lavker RM, Wheelock MJ (1997) E-cadherin and P-cadherin have partially redundant roles in human epidermal stratification. Cell Tissue Res 288(2):307-316
58. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP (1996) Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272(5268):1668-1671
59. Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE, Brash DE (1996) Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 93(24):14025-14029
60. Kajino Y, Yamaguchi A, Hashimoto N, Matsuura A, Sato N, Kikuchi K (2001) beta-Catenin gene mutation in human hair folliclerelated tumors. Pathol Int 51(7):543-548
61. Kallassy M, Toftgard R, Ueda M, Nakazawa K, Vorechovsky I, Yamasaki H, Nakazawa H (1997) Patched (ptch)-Associated preferential expression of smoothened (smoh) in human basal cell carcinoma of the skin. Cancer Res 57(21):4731-4735
62. Kemp CJ, Donehower LA, Bradley A, Balmain A (1993) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 74:813-822
63. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marme D, Rapp UR (1993) Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364(6434):249-252
64. Kopp-Schneider A, Portier CJ (1992) Birth and death/differentiation rates of papillomas in mouse skin. Carcinogenesis 13(6):973-978
65. Kraemer KH (1997) Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci U S A 94(1):11-14
66. Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwarz M (1992) Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res 52:6400-6403
67. Kwa RE, Campana K, Moy RL (1992) Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26(1):1-26
68. Lazar AJ, Calonje E, Grayson W, Dei Tos AP, Mihm MC Jr, Redston M, McKee PH (2005) Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol 32(2):148-157
69. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16(1):64-67
70. Lustig B, Behrens J (2003) The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 129(4):199-221
71. Lutz WK, Beland PE, Candrian R, Fekete T, Fischer WH (1996) Dose-Time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-Tetradecanoyl-phorbol-13-Acetate. Regul Toxicol Pharmacol 23(1 Pt 1):44-48
72. Malanchi I, Peinado H, Kassen D, Hussenet T, Metzger D, Chambon P, Huber M, Hohl D, Cano A, Birchmeier W, Huelsken J (2008) Cutaneous cancer stem cell maintenance is dependent on betacatenin signalling. Nature 452(7187):650-653
73. Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30 years. Nat Rev Cancer 3(6):459-465
74. Manoukian AS, Woodgett JR (2002) Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 84:203-229
75. Marais R, Light Y, Mason C, Paterson H, Olson MF, Marshall CJ (1998) Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280(5360):109-112
76. Marks F, Furstenberger G (1990) The conversion stage of skin carcinogenesis. Carcinogenesis 11(12):2085-2092
77. Marks F, Schwarz M, Fürstenberger G (1995) Promotion and cocarcinogenesis. In: Arcos JC, Argus MF, Woo YT (eds) Chemical induction of cancer. Birkhäuser, Boston, pp 123-160
78. Marte BM, Downward J (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22(9):355-358
79. Martinez VD, Becker-Santos DD, Vucic EA, Lam S, Lam WL (2011) Induction of human squamous cell-Type carcinomas by arsenic. J Skin Cancer 2011:454157
80. McGrath JA, McMillan JR, Shemanko CS, Runswick SK, Leigh IM, Lane EB, Garrod DR, Eady RA (1997) Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat Genet 17(2):240-244
81. Miller SJ, Sun TT, Lavker RM (1993) Hair follicles, stem cells, and skin cancer. J Invest Dermatol 100(3):288S-294S
82. Moolgavkar SH (1983) Model for human carcinogenesis: action of environmental agents. Environ Health Perspect 50:285-291
83. Moraitis AN, Giguere V (2003) The co-repressor hairless protects RORalpha orphan nuclear receptor from proteasome-mediated degradation. J Biol Chem 278(52):52511-52518
84. Mottram JC (1944) A developing factor in experimental blastogenesis. J Pathol Bacteriol 56(2):181-187
85. Mueller MM (2006) Inflammation in epithelial skin tumours: old stories and new ideas. Eur J Cancer 42(6):735-744
86. NishizukaY(1988) The molecular heterogeneity of protein kinaseCand its implications for cellular regulation. Nature 334(6184):661-665
87. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein EH Jr, Scott MP (1997) Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276(5313):817-821
88. Owens DM, Watt FM (2003) Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 3(6): 444-451
89. Palmer HG, Anjos-Afonso F, Carmeliet G, Takeda H, Watt FM (2008) The vitamin D receptor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult epidermis. PLoS ONE 3(1):e1483
90. Perez-Losada J, Balmain A (2003) Stem-cell hierarchy in skin cancer. Nat Rev Cancer 3(6):434-443
91. Poland A, Palen D, Glover E (1982) Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature 300:271-273
92. Potten CS (1974) The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinet 7(1):77-88
93. Potter GB, Beaudoin GM 3rd, DeRenzo CL, Zarach JM, Chen SH, Thompson CC (2001) The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev 15(20):2687-2701
94. Poulikakos PI, Zhang C, Bollag G, Shokat KM, Rosen N (2010) RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-Type BRAF. Nature 464(7287):427-430
95. Quintanilla M, Brown K, Ramsden M, Balmain A (1986) Carcinogenspecific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322(6074):78-80
96. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370(6490):527-532
97. Rose-John S, Furstenberger G, Krieg P, Besemfelder E, Rincke G, Marks F (1988) Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo. Carcinogenesis 9(5):831-835
98. Rous P, Kidd JG (1941) Conditional neoplasms and subthreshold neoplastic states : a study of the tar tumors of rabbits. J Exp Med 73(3):365-390
99. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T, Klein-Szanto AJP (1993) Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci USA 90:1013-1017
100. Rundhaug JE, Fischer SM (2010) Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) 2(2):436-482
101. Saitoh A, Hansen LA, Vogel JC, Udey MC (1998) Characterization of Wnt gene expression in murine skin: possible involvement of epidermis-derived Wnt-4 in cutaneous epithelial-mesenchymal interactions. Exp Cell Res 243(1):150-160
102. Schweizer J, Marks F (1977) Induction of the formation of new hair follicles in mouse tail epidermis by the tumor promoter 12- Otetradecanoylphorbol-13-Acetate. Cancer Res 37(11):4195-4201
103. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5):593-602
104. Shubik P (1950) Studies on the promoting phase in the stages of carcinogenesis in mice, rats, rabbits, and guinea pigs. Cancer Res 10(1):13-17
105. Sidransky D (1996) Is human patched the gatekeeper of common skin cancerš Nat Genet 14(1):7-8
106. Silva-Vargas V, Lo Celso C, Giangreco A, Ofstad T, Prowse DM, Braun KM, Watt FM (2005) Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells. Dev Cell 9(1):121-131
107. Sisskin EE, Barrett JC (1981) Hyperplasia of Syrian hamster epidermis induced by single but not multiple treatments with 12-Otetradecanoylphorbol-13- Acetate. Cancer Res 41(1):346-350
108. Slaga TJ (1986) SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice. Environ Health Perspect 68:27-32
109. Slaga TJ, Fischer SM, Nelson K, Gleason GL (1980) Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci U S A 77(6):3659-3663
110. Slaga TJ, DiGiovanni J, Winberg LD, Budunova IV (1995) Skin carcinogenesis: characteristics, mechanisms, and prevention. Prog Clin Biol Res 391:1-20
111. Slusarski DC, Corces VG, Moon RT (1997) Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390(6658):410-413
112. Stenback F, Arranto A (1985) Initiation and promotion in young and old animals. Implications for human tumour formation. IARC Sci Publ 58:151-166
113. Stern MC, Gimenez-Conti I, Budunova I, Coghlan L, Fischer SM, DiGiovanni J, Slaga TJ, Conti CJ (1998) Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression. Carcinogenesis 19(1):125-132
114. Strutt DI, Weber U, Mlodzik M (1997) The role of RhoA in tissue polarity and Frizzled signalling. Nature 387(6630):292-295
115. Su F, Viros A, Milagre C, Trunzer K, Bollag G, Spleiss O, Reis-Filho JS, Kong X, Koya RC, Flaherty KT, Chapman PB, Kim MJ, Hayward R, Martin M, Yang H, Wang Q, Hilton H, Hang JS, Noe J, Lambros M, Geyer F, Dhomen N, Niculescu-Duvaz I, Zambon A, Niculescu-Duvaz D, Preece N, Robert L, Otte NJ, Mok S, Kee D, Ma Y, Zhang C, Habets G, Burton EA, Wong B, Nguyen H, Kockx M, Andries L, Lestini B, Nolop KB, Lee RJ, Joe AK, Troy JL, Gonzalez R, Hutson TE, Puzanov I, Chmielowski B, Springer CJ, McArthur GA, Sosman JA, Lo RS, Ribas A, Marais R (2012) RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors. N Engl J Med 366(3):207-215
116. Suganuma M, Okabe S, Kurusu M, Iida N, Ohshima S, Saeki Y, Kishimoto T, Fujiki H (2002) Discrete roles of cytokines, TNFalpha, IL-1, IL-6 in tumor promotion and cell transformation. Int J Oncol 20(1):131-136
117. Sun P, Yoshizuka N, New L, Moser BA, Li Y, Liao R, Xie C, Chen J, Deng Q, Yamout M, Dong MQ, Frangou CG, Yates JR 3rd, Wright PE, Han J (2007) PRAK is essential for ras-induced senescence and tumor suppression. Cell 128(2):295-308
118. Suzuki A, Itami S, Ohishi M, Hamada K, Inoue T, Komazawa N, Senoo H, Sasaki T, Takeda J, Manabe M, Mak TW, Nakano T (2003) Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 63(3):674-681
119. Tokar EJ, Benbrahim-Tallaa L, Ward JM, Lunn R, Sams RL 2nd, Waalkes MP (2010) Cancer in experimental animals exposed to arsenic and arsenic compounds. Crit Rev Toxicol 40(10):912-927
120. Trakul N, Menard RE, Schade GR, Qian Z, Rosner MR (2005) Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem 280(26):24931-24940
121. Trempus CS, Morris RJ, Bortner CD, Cotsarelis G, Faircloth RS, Reece JM, Tennant RW (2003) Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol 120(4):501-511
122. Trempus CS, Morris RJ, Ehinger M, Elmore A, Bortner CD, Ito M, Cotsarelis G, Nijhof JG, Peckham J, Flagler N, Kissling G, Humble MM, King LC, Adams LD, Desai D, Amin S, Tennant RW (2007) CD34 expression by hair follicle stem cells is required for skin tumor development in mice. Cancer Res 67(9):4173-4181
123. Udell CM, Rajakulendran T, Sicheri F, Therrien M (2011) Mechanistic principles of RAF kinase signaling. Cell Mol Life Sci 68(4):553-565
124. Watt FM (1998) Epidermal stem cells: markers, patterning and the control of stem cell fate. Philos Trans R Soc Lond B Biol Sci 353(1370):831-837
125. Wiriyachitra P, Hajiwangoh H, Boonton P, Adolf W, Opferkuch HJ, Hecker E (1985) Investigations of medicinal plants of euphorbiaceae and thymelaeaceae occurring and used in Thailand; II. Cryptic irritants of the diterpene ester type from three Excoecaria species. Planta Med 5:368-371
126. Woodworth CD, Michael E, Smith L, Vijayachandra K, Glick A, Hennings H, Yuspa SH (2004) Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis 25(9): 1771-1778
127. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein EH Jr, de Sauvage FJ (1998) Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391(6662):90-92
128. Xie Z, Chang S, Oda Y, Bikle DD (2006) Hairless suppresses vitamin D receptor transactivation in human keratinocytes. Endocrinology 147(1):314-323
129. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445(7128):656-660
130. Yuspa SH (1986) Cutaneous chemical carcinogenesis. J Am Acad Dermatol 15(5 Pt 1):1031-1044
131. Zayed SM, Farghaly M, Soliman SM, Gotta H, Sorg B, Hecker E (2001) Dietary cancer risk from conditional cancerogens (tumor promoters) in produce of livestock fed on species of spurge (Euphorbiaceae). V. Skin irriitant and tumor-promoting diterpene ester toxins of the tigliane and ingenane type in the herbs Euphorbia nubica and Euphorbia helioscopia contaminating fodder of livestock. J Cancer Res Clin Oncol 127(1):40-47